These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 16772708

  • 1. Effect of erythropoietin on urinary liver-type fatty-acid-binding protein in patients with chronic renal failure and anemia.
    Nakamura T, Sugaya T, Kawagoe Y, Suzuki T, Ueda Y, Koide H.
    Am J Nephrol; 2006; 26(3):276-80. PubMed ID: 16772708
    [Abstract] [Full Text] [Related]

  • 2. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy.
    Nakamura T, Sugaya T, Node K, Ueda Y, Koide H.
    Am J Kidney Dis; 2006 Mar; 47(3):439-44. PubMed ID: 16490622
    [Abstract] [Full Text] [Related]

  • 3. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N, Osman-Malik Y, Frinak S, Besarab A.
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [Abstract] [Full Text] [Related]

  • 4. Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy.
    Hofstra JM, Deegens JK, Steenbergen EJ, Wetzels JF.
    Nephrol Dial Transplant; 2008 Oct; 23(10):3160-5. PubMed ID: 18403431
    [Abstract] [Full Text] [Related]

  • 5. Renovascular protective effects of erythropoietin in patients with chronic kidney disease.
    Fujiwara N, Nakamura T, Sato E, Kawagoe Y, Hikichi Y, Ueda Y, Node K.
    Intern Med; 2011 Oct; 50(18):1929-34. PubMed ID: 21921371
    [Abstract] [Full Text] [Related]

  • 6. Metabolic effects of keto acid--amino acid supplementation in patients with chronic renal insufficiency receiving a low-protein diet and recombinant human erythropoietin--a randomized controlled trial.
    Teplan V, Schück O, Votruba M, Poledne R, Kazdová L, Skibová J, Malý J.
    Wien Klin Wochenschr; 2001 Sep 17; 113(17-18):661-9. PubMed ID: 11603100
    [Abstract] [Full Text] [Related]

  • 7. Factor deficiency in the anemia of renal transplant patients with grade III-IV chronic kidney disease: baseline results of the ARES Study.
    Gentil MA, Pérez-Valdivia MA, López-Mendoza M, Ortega F, Arias M, Gómez-Alamillo C, Campistol JM, ARES Study Group.
    Transplant Proc; 2008 Nov 17; 40(9):2922-4. PubMed ID: 19010148
    [Abstract] [Full Text] [Related]

  • 8. Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.
    Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Osada S, Koide H.
    Diabetes Care; 2005 Nov 17; 28(11):2728-32. PubMed ID: 16249547
    [Abstract] [Full Text] [Related]

  • 9. Oral adsorbent AST-120 ameliorates tubular injury in chronic renal failure patients by reducing proteinuria and oxidative stress generation.
    Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Suzuki T, Ueda Y, Yamagishi S.
    Metabolism; 2011 Feb 17; 60(2):260-4. PubMed ID: 20189611
    [Abstract] [Full Text] [Related]

  • 10. Effect of pitavastatin on urinary liver-type fatty-acid-binding protein in patients with nondiabetic mild chronic kidney disease.
    Nakamura T, Sugaya T, Kawagoe Y, Suzuki T, Inoue T, Node K.
    Am J Nephrol; 2006 Feb 17; 26(1):82-6. PubMed ID: 16534182
    [Abstract] [Full Text] [Related]

  • 11. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A, Silverberg D, Iovine F, Capobianco S, Giannotti G, Calabrò A, Campagna SM, Nuti R.
    Am Heart J; 2006 Dec 17; 152(6):1096.e9-15. PubMed ID: 17161060
    [Abstract] [Full Text] [Related]

  • 12. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.
    Ther Apher Dial; 2010 Jun 17; 14(3):240-75. PubMed ID: 20609178
    [Abstract] [Full Text] [Related]

  • 13. Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis.
    Hall AM, Edwards SG, Lapsley M, Connolly JO, Chetty K, O'Farrell S, Unwin RJ, Williams IG.
    Am J Kidney Dis; 2009 Dec 17; 54(6):1034-42. PubMed ID: 19783343
    [Abstract] [Full Text] [Related]

  • 14. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS, Blum M, Agbaria Z, Deutsch V, Irony M, Schwartz D, Baruch R, Yachnin T, Steinbruch S, Iaina A.
    Clin Nephrol; 2001 Mar 17; 55(3):212-9. PubMed ID: 11316241
    [Abstract] [Full Text] [Related]

  • 15. Effect of red wine on urinary protein, 8-hydroxydeoxyguanosine, and liver-type fatty acid-binding protein excretion in patients with diabetic nephropathy.
    Nakamura T, Fujiwara N, Sugaya T, Ueda Y, Koide H.
    Metabolism; 2009 Aug 17; 58(8):1185-90. PubMed ID: 19481229
    [Abstract] [Full Text] [Related]

  • 16. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R, Besarab A, Macdougall IC, Ellison DH, Maxwell AP, Sulowicz W, Klinger M, Rutkowski B, Correa-Rotter R, Dougherty FC, BA 16528 Study Investigators.
    Clin Nephrol; 2007 May 17; 67(5):306-17. PubMed ID: 17542340
    [Abstract] [Full Text] [Related]

  • 17. Treatment of anemia in renal transplantation: impact of a stricter application of hemoglobin targets.
    Gentil MA, Pérez-Valdivia MA, González-Roncero FM, López-Mendoza M, Cabello V, Bernal G, Suñer M, Pereira P.
    Transplant Proc; 2008 Nov 17; 40(9):2916-8. PubMed ID: 19010146
    [Abstract] [Full Text] [Related]

  • 18. Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10 g/dL.
    Ayus JC, Go AS, Valderrabano F, Verde E, de Vinuesa SG, Achinger SG, Lorenzo V, Arieff AI, Luño J, Spanish Group for the Study of the Anemia and Left Ventricular Hypertrophy in Pre-dialysis Patients.
    Kidney Int; 2005 Aug 17; 68(2):788-95. PubMed ID: 16014057
    [Abstract] [Full Text] [Related]

  • 19. The prevalence of anemia in patients with chronic kidney disease.
    McClellan W, Aronoff SL, Bolton WK, Hood S, Lorber DL, Tang KL, Tse TF, Wasserman B, Leiserowitz M.
    Curr Med Res Opin; 2004 Sep 17; 20(9):1501-10. PubMed ID: 15383200
    [Abstract] [Full Text] [Related]

  • 20. Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy.
    Nakamura T, Inoue T, Sugaya T, Kawagoe Y, Suzuki T, Ueda Y, Koide H, Node K.
    Am J Hypertens; 2007 Nov 17; 20(11):1195-201. PubMed ID: 17954367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.